窪蹋勛圖厙

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 窪蹋勛圖厙 News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jan 24 2020

Full Issue

Lab-Grown Venom Glands Could Open Door To Better, More Modern Way To Treat Snakebites

Making antivenom still involves milking a snake, injecting a horse with the venom, and then collecting antibodies from the horse. Lab-grown venom glands could modernize the process. In other public health news: depression, genetic testing, uterine fibroids, deadly genetic mutations, and more.

The procurement allowed the researchers to grow organoids of the snake venom glands essentially miniature 3D versions cultivated in lab dishes. And in doing so, they opened the door to potential discoveries that could help human health. That first egg belonged to a Cape coral snake, also known as a Cape coral cobra. With the specimen in hand, Clevers and his team removed the snake from the egg before it hatched, excised tissue samples, and then grew the venom gland organoid, they reported Thursday in Cell. They did the same with eight other species. (Joseph, 1/23)

People with depression are at increased risk for dementia, researchers report, and the risk may persist for decades. Using the Swedish National Patient Register, scientists identified 119,386 people over 50 with depression and matched them with an equal number of people without that diagnosis. (Bakalar, 1/23)

In the latest sign of a slump in consumer genetic testing, 23andMe is laying off 14% of its workforce amid falling sales of its DNA spit kits. The cut of about 100 jobs, which could be the companys largest downsize yet, will mostly impact 23andMes operations teams, CEO Anne Wojcicki told CNBC on Thursday. A company spokesperson, Christine Pai, told STAT in an email: What I can confirm is that we are restructuring the consumer business, which impacts about 14% of employees. Our therapeutics business is not impacted. Were also narrowing focus on the core businesses consumer and therapeutics. (Brodwin, 1/23)

For millions of premenopausal women, uterine fibroids turn their monthly periods into virtual hemorrhages. A new drug called elagolix cut blood loss by half over six months in the overwhelming majority of women who participated in two clinical trials published Wednesday in the New England Journal of Medicine.(McCullough, 1/22)

Over more than a decade, an additional 16 children from two extended Amish families would die before researchers pinpointed the culprit: a rare genetic mutation. The details were described this month in a study led by the Mayo Clinic, along with researchers from the Alfred I. DuPont Hospital for Children in Wilmington and other institutions. (Avril, 1/23)

Immigrants face unique stressors that may contribute to mental health problems and are less likely to seek help for them. Here are some of the best ways for immigrant communities to start therapy. (Hodges, 1/23)

Blood is no longer blue for Kotex. A new ad campaign for the Kimberly-Clark Corp. brand is using a realistic-looking red fluid, rather than the ubiquitous antiseptic-blue liquid, to represent menstrual blood. Kimberly-Clarks approach to marketing its U by Kotex products on social media and streaming TV comes as more companies look to tap into a movement to end the squeamishness and stigma around womens health and grooming needs, from body hair to bladder leaks and menopause, that have been standard in such marketing for decades. (Terlep, 1/23)

More than a year after the Thanksgiving outbreak, the E. coli threat is as real as it ever was, and the government still lacks the means, and maybe the will, to take it on, a six-month Globe review finds. There have been four E. coli outbreaks traced to lettuce since September alone, sickening people in more than two dozen states. Since 2017, there are nearly 500 documented victims and six deaths from leafy green vegetables contaminated by E. coli. Because the disease is difficult to document, the actual numbers are likely many times higher. (Haughney, 1/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 窪蹋勛圖厙
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

穢 2026 KFF